These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27421764)

  • 1. Does the type of progestin influence the production of clotting factors?
    Stanczyk FZ; Mathews BW; Cortessis VK
    Contraception; 2017 Feb; 95(2):113-116. PubMed ID: 27421764
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis.
    Farris M; Bastianelli C; Rosato E; Brosens I; Benagiano G
    Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1129-1144. PubMed ID: 28712325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestin-only contraception and venous thromboembolism.
    Blanco-Molina MA; Lozano M; Cano A; Cristobal I; Pallardo LP; Lete I
    Thromb Res; 2012 May; 129(5):e257-62. PubMed ID: 22425318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.
    Shulman LP
    Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serious adverse effect of combined oral contraceptive pills among teenagers].
    Nylander MC; Clausen HV
    Ugeskr Laeger; 2014 Jun; 176(26):V05130336. PubMed ID: 25294576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous hormones, the risk of venous thromboembolism, and activated protein C resistance.
    Mueck AO
    Menopause; 2010; 17(6):1099-103. PubMed ID: 20975607
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biological monitoring of oral estroprogestagen contraception].
    ANAES Agence nationale d'accréditation et d'evaluation en santé
    Gynecol Obstet Fertil; 2001 Mar; 29(3):254-6. PubMed ID: 11305289
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies.
    Shapiro S; Dinger J
    J Fam Plann Reprod Health Care; 2010 Jan; 36(1):33-8. PubMed ID: 20067670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined oral contraception and hypercoagulation].
    Adukauskiene D; Miliauskiene V
    Medicina (Kaunas); 2010; 46(4):293-7. PubMed ID: 20571299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism'.
    Terplan M; Zuckerman D
    J Fam Plann Reprod Health Care; 2013 Oct; 39(4):304. PubMed ID: 24062505
    [No Abstract]   [Full Text] [Related]  

  • 11. Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.
    Hugon-Rodin J; Horellou MH; Conard J; Gompel A; Plu-Bureau G
    Thromb Haemost; 2018 May; 118(5):922-928. PubMed ID: 29614525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
    Bitzer J; Amy JJ; Beerthuizen R; Birkhäuser M; Bombas T; Creinin M; Darney PD; Vicente LF; Gemzell-Danielsson K; Imthurn B; Jensen JT; Kaunitz AM; Kubba A; Lech MM; Mansour D; Merki G; Rabe T; Sedlecki K; Serfaty D; Seydoux J; Shulman LP; Sitruk-Ware R; Skouby SO; Szarewski A; Trussell J; Westhoff C
    J Fam Plann Reprod Health Care; 2013 Jul; 39(3):156-9. PubMed ID: 23585363
    [No Abstract]   [Full Text] [Related]  

  • 13. Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
    Bitzer J; Amy JJ; Beerthuizen R; Birkhäuser M; Bombas T; Creinin M; Darney PD; Vicente LF; Gemzell-Danielsson K; Imthurn B; Jensen JT; Kaunitz AM; Kubba A; Lech MM; Mansour D; Merki G; Rabe T; Sedlecki K; Serfaty D; Seydoux J; Shulman LP; Sitruk-Ware R; Skouby SO; Szarewski A; Trussell J; Westhoff C
    Eur J Contracept Reprod Health Care; 2013 Jun; 18(3):143-7. PubMed ID: 23578274
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism': author's response.
    Bitzer J
    J Fam Plann Reprod Health Care; 2013 Oct; 39(4):304-5. PubMed ID: 24062506
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study.
    Le Moigne E; Tromeur C; Delluc A; Gouillou M; Alavi Z; Lacut K; Mottier D; Le Gal G
    Haematologica; 2016 Jan; 101(1):e12-4. PubMed ID: 26452982
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiovascular risks of combined oral contraceptives - beyond the French controversy].
    Gronier H; Robin G
    Gynecol Obstet Fertil; 2014 Mar; 42(3):174-81. PubMed ID: 24582295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of thromboembolism associated with hormone contraceptives in Japanese compared with Western women.
    Kobayashi T; Sugiura K; Ojima T
    J Obstet Gynaecol Res; 2017 May; 43(5):789-797. PubMed ID: 28422361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraception, venous thrombosis and biological plausability.
    Rott H
    Minerva Med; 2013 Apr; 104(2):161-7. PubMed ID: 23514992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Venous pathology with estrogens-progestagens].
    Vin F; Allaert FA; Levardon M
    Phlebologie; 1989; 42(3):473-9; discussion 479-80. PubMed ID: 2626469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.